NASDAQ : GILD

Gilead Sciences, Inc. — Financial statements

Healthcare · Drug Manufacturers - General · United States

Last price 165.61 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 205.35B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Gilead Sciences, Inc. (GILD) reported revenue of 30.99B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Operating Revenue30.99B29.44B28.75B27.12B27.28B27.30B
Other Revenue1.00M1.00M
Revenue30.99B29.44B28.75B27.12B27.28B27.30B
Cost of Revenue6.21B6.23B6.25B5.97B5.66B5.53B
Gross Profit24.77B23.21B22.50B21.15B21.62B21.78B
Selling, General & Admin6.72B5.71B6.00B6.06B5.67B5.25B
Research & Development6.21B5.69B5.82B5.76B4.98B4.60B
Operating Expenses12.93B11.40B11.82B11.82B10.65B9.85B
Operating Income11.85B11.82B10.69B9.33B10.97B11.93B
Interest Expense-1.01B-1.02B-977.00M-944.00M-935.00M-1.00B
Interest & Investment Income276.00M349.00M281.00M376.00M106.00M
Currency Exchange Gain (Loss)3.00M-29.00M14.00M-12.00M-23.00M
Other Non Operating Income (Expenses)-12.00M27.00M-15.00M2.00M-30.00M-6.00M
EBT Excluding Unusual Items11.10B11.14B9.99B8.75B10.12B10.90B
Merger & Restructuring Charges-136.00M-138.00M-189.00M-527.00M
Gain (Loss) on Sale of Investments574.00M451.00M-274.00M-167.00M-657.00M-610.00M
Asset Writedown-51.00M
Legal Settlements-1.07B
Other Unusual Items-76.00M-43.00M7.00M60.00M
Pretax Income-2.53B9.80B691.00M6.86B5.81B8.28B
Income Tax Expense1.33B1.29B211.00M1.25B1.25B2.08B
Earnings From Continuing Operations-3.86B8.51B480.00M5.61B4.57B6.20B
Minority Interest in Earnings52.00M26.00M24.00M
Net Income-3.86B8.51B480.00M5.67B4.59B6.22B
Net Income to Common-3.86B8.51B480.00M5.67B4.59B6.22B
Shares Outstanding (Basic)1.24B1.24B1.25B1.25B1.25B1.26B
Shares Outstanding (Diluted)1.24B1.25B1.25B1.26B1.26B1.26B
EPS (Basic)-3.116.840.384.543.664.96
EPS (Diluted)-3.126.780.384.503.644.93
Free Cash Flow13.78B9.46B10.30B7.42B8.34B10.80B
Free Cash Flow Per Share11.107.548.215.906.618.56
Dividend Per Share3.253.163.083.002.922.84
Gross Margin79.95%78.84%78.26%77.99%79.26%79.76%
Operating Margin38.23%40.13%37.17%34.40%40.23%43.70%
Profit Margin-12.46%28.90%1.67%20.89%16.83%22.80%
Free Cash Flow Margin44.47%32.12%35.84%27.37%30.59%39.57%
EBITDA14.66B14.58B13.45B12.02B13.08B13.98B
EBITDA Margin47.31%49.51%46.79%44.33%47.93%51.21%
D&A For EBITDA2.81B2.76B2.77B2.69B2.10B2.05B
EBIT11.85B11.82B10.69B9.33B10.97B11.93B
EBIT Margin38.23%40.13%37.17%34.40%40.23%43.70%
Effective Tax Rate13.13%30.54%18.18%21.46%25.09%
Revenue as Reported30.99B29.44B28.75B27.12B27.28B27.30B
Advertising Expenses1.00B869.00M826.00M778.00M735.00M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents6.44B7.56B9.99B6.08B5.41B5.34B
Short-Term Investments1.51B2.05B1.58B2.27B1.45B2.07B
Cash & Short-Term Investments7.95B9.61B11.57B8.35B6.86B7.41B
Accounts Receivable5.01B4.91B4.42B4.66B4.78B4.49B
Receivables5.01B4.91B4.42B4.66B4.78B4.49B
Inventory1.90B1.77B1.71B1.79B1.51B1.62B
Prepaid Expenses1.64B899.00M480.00M559.00M1.24B1.18B
Other Current Assets60.00M1.14B995.00M729.00M60.00M75.00M
Total Current Assets16.55B18.34B19.17B16.09B14.44B14.77B
Property, Plant & Equipment5.95B6.14B5.93B5.90B5.98B5.66B
Long-Term Investments734.00M3.75B713.00M1.82B2.61B2.84B
Goodwill8.31B8.31B8.31B8.31B8.31B8.33B
Other Intangible Assets13.42B16.98B19.95B26.45B28.89B33.45B
Long-Term Deferred Tax Assets2.27B1.96B2.38B
Other Long-Term Assets4.17B3.53B2.54B3.56B2.93B2.89B
Total Assets51.41B59.02B58.99B62.12B63.17B67.95B
Accounts Payable934.00M715.00M833.00M550.00M905.00M705.00M
Accrued Expenses4.62B5.63B5.12B5.00B4.50B7.00B
Current Portion of Long-Term Debt2.42B2.81B1.81B1.80B2.27B1.52B
Current Portion of Leases102.00M113.00M125.00M111.00M101.00M
Current Income Taxes Payable92.00M1.65B1.21B959.00M539.00M
Other Current Liabilities4.03B2.46B2.48B2.60B2.49B1.75B
Total Current Liabilities12.00B11.81B12.00B11.28B11.24B11.61B
Long-Term Debt23.82B22.13B24.90B23.19B22.96B25.18B
Long-Term Leases503.00M498.00M546.00M467.00M489.00M
Long-Term Deferred Tax Liabilities318.00M402.00M724.00M1.59B2.67B4.36B
Other Long-Term Liabilities2.32B1.56B1.63B2.77B4.63B5.25B
Total Liabilities38.45B36.41B39.75B39.38B41.96B46.89B
Common Stock1.00M1.00M1.00M1.00M1.00M1.00M
Additional Paid-In Capital9.84B8.93B7.70B6.50B5.55B4.66B
Retained Earnings3.11B13.73B11.50B16.30B15.69B16.32B
Comprehensive Income & Other91.00M39.00M132.00M28.00M2.00M83.00M
Total Common Equity13.04B22.70B19.33B22.83B21.24B21.07B
Minority Interest-84.00M-84.00M-84.00M-84.00M-31.00M-5.00M
Shareholders' Equity12.96B22.62B19.25B22.75B21.21B21.06B
Total Liabilities & Equity51.41B59.02B58.99B62.12B63.17B67.95B
Total Debt26.23B25.54B27.32B25.66B25.81B27.29B
Net Cash (Debt)-18.28B-12.95B-15.75B-16.14B-17.70B-18.57B
Net Cash Per Share-14.72-10.32-12.55-12.83-14.03-14.72
Filing Date Shares Outstanding1.24B1.24B1.25B1.25B1.25B1.25B
Total Common Shares Outstanding1.24B1.24B1.25B1.25B1.25B1.25B
Working Capital4.55B6.53B7.17B4.80B3.21B3.16B
Book Value Per Share10.5118.2915.5118.3317.0316.80
Tangible Book Value-8.70B-2.59B-8.93B-11.94B-15.97B-20.72B
Tangible Book Value Per Share-7.01-2.09-7.17-9.58-12.81-16.52
Land561.00M561.00M561.00M562.00M404.00M
Buildings4.62B4.54B4.33B4.39B3.79B
Machinery1.24B1.19B2.22B1.99B1.76B
Construction In Progress745.00M501.00M661.00M719.00M1.06B

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-3.86B8.51B480.00M5.67B4.59B6.22B
Depreciation & Amortization2.81B2.76B2.77B2.69B2.10B2.05B
Asset Writedown & Restructuring Costs14.86B1.61B8.84B1.21B3.64B939.00M
Loss (Gain) From Sale of Investments-574.00M-451.00M274.00M167.00M657.00M610.00M
Stock-Based Compensation913.00M894.00M835.00M766.00M637.00M635.00M
Other Operating Activities596.00M640.00M-1.49B-187.00M-798.00M436.00M
Change in Accounts Receivable32.00M-367.00M139.00M157.00M-406.00M313.00M
Change in Inventory-572.00M-1.04B-426.00M-842.00M-310.00M11.00M
Change in Accounts Payable110.00M-132.00M290.00M-347.00M226.00M-118.00M
Change in Income Taxes-364.00M-361.00M
Change in Other Net Operating Assets-47.00M-305.00M-151.00M497.00M-909.00M644.00M
Operating Cash Flow14.48B10.02B10.83B8.01B9.07B11.38B
Capital Expenditures-699.00M-563.00M-523.00M-585.00M-728.00M-579.00M
Cash Acquisitions-11.95B-1.07B-4.84B-1.15B-1.80B-1.58B
Investment in Securities1.96B-3.16B1.86B-528.00M60.00M-987.00M
Other Investing Activities28.00M3.00M58.00M-1.00M19.00M
Investing Cash Flow-10.66B-4.79B-3.45B-2.27B-2.47B-3.13B
Long-Term Debt Issued3.46B1.98B
Long-Term Debt Repaid-1.79B-1.97B-2.25B-1.50B-4.75B
Net Debt Issued (Repaid)1.27B-1.79B1.49B-270.00M-1.50B-4.75B
Issuance of Common Stock294.00M408.00M422.00M232.00M309.00M169.00M
Repurchase of Common Stock-1.37B-1.92B-1.15B-1.00B-1.40B-546.00M
Common Dividends Paid-4.10B-4.00B-3.92B-3.81B-3.71B-3.60B
Other Financing Activities-779.00M-440.00M-281.00M-278.00M-173.00M-145.00M
Financing Cash Flow-4.69B-7.75B-3.43B-5.12B-6.47B-8.88B
Foreign Exchange Rate Adjustments-29.00M92.00M-40.00M57.00M-63.00M-35.00M
Net Cash Flow-893.00M-2.43B3.91B673.00M74.00M-659.00M
Free Cash Flow13.78B9.46B10.30B7.42B8.34B10.80B
Free Cash Flow Margin44.47%32.12%35.84%27.37%30.59%39.57%
Free Cash Flow Per Share11.107.548.215.906.618.56
Levered Free Cash Flow10.68B7.54B10.13B8.50B6.94B10.20B
Unlevered Free Cash Flow11.31B8.18B10.74B9.09B7.52B10.83B
Cash Interest Paid1.04B1.04B951.00M891.00M907.00M979.00M
Cash Income Tax Paid3.21B3.21B2.78B3.99B3.14B2.51B
Change in Working Capital-265.00M-3.95B-880.00M-2.30B-1.76B489.00M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization211.27B152.28B115.12B100.94B107.68B91.08B
Enterprise Value229.55B166.64B131.59B116.72B125.36B111.06B
Last Close Price170.68120.5788.2774.3775.8961.38
PE Ratio17.89239.8317.8223.4514.63
Forward PE20.7714.5712.5510.8812.9010.79
PS Ratio6.825.174.003.723.953.34
PB Ratio16.246.735.984.445.084.32
P/FCF Ratio15.3316.1011.1713.6012.908.43
P/OCF Ratio14.5915.2010.6312.6111.878.00
PEG Ratio2.860.650.740.938.4241.29
EV/Sales Ratio7.415.664.584.304.594.07
EV/EBITDA Ratio15.6611.439.789.719.597.94
EV/EBIT Ratio19.3814.1012.3112.5111.429.31
EV/FCF Ratio16.6617.6212.7715.7315.0210.28
Debt / Equity Ratio2.021.131.421.131.221.29
Debt / EBITDA Ratio1.771.732.012.111.951.93
Debt / FCF Ratio1.902.702.653.463.092.52
Net Debt / Equity Ratio1.410.570.820.710.830.88
Net Debt / EBITDA Ratio1.250.891.171.341.351.33
Net Debt / FCF Ratio1.331.371.532.182.121.72
Asset Turnover0.560.500.470.430.420.40
Inventory Turnover3.383.583.583.623.623.35
Quick Ratio1.081.231.331.151.031.02
Current Ratio1.381.551.601.431.281.27
Return on Equity (ROE)-22.45%40.66%2.29%25.54%21.60%31.57%
Return on Assets (ROA)13.47%12.52%11.03%9.31%10.46%10.94%
Return on Invested Capital (ROIC)36.82%27.92%19.78%19.03%21.25%21.68%
Return on Capital Employed (ROCE)30.10%25.00%22.70%18.30%21.10%21.20%
Earnings Yield-1.83%5.59%0.42%5.61%4.26%6.83%
FCF Yield6.52%6.21%8.95%7.35%7.75%11.86%
Dividend Yield1.93%2.57%3.33%3.70%3.38%3.91%
Payout Ratio47.04%816.25%67.24%80.77%57.91%
Buyback Yield / Dilution1.58%0.24%0.24%0.32%0.08%0.08%
Total Shareholder Return3.51%2.82%3.57%4.02%3.46%3.99%